| Aliza Calm, | |
|
511 Jermor Ln Ste 102, Westminster, MD 21157-6152 | |
| (410) 871-2494 | |
| Not Available |
| Full Name | Aliza Calm |
|---|---|
| Gender | Female |
| Speciality | Qualified Speech Language Pathologist |
| Experience | 7 Years |
| Location | 511 Jermor Ln Ste 102, Westminster, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154993665 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 08970 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Accessible Speech Therapy, Llc | 7214344282 | 2 |
News Archive
MorphoSys AG and G7 Therapeutics AG announced today that they have signed an agreement to collaborate on novel antibody therapeutics targeting G protein-coupled receptors and potentially other disease-related transmembrane proteins such as ion channels.
The Centers for Disease Control and Prevention (CDC) recently released its Global Health Strategy 2012-2015, which "outlines how CDC will leverage its core strengths to advance four overarching global health goals: improving the health and well-being of people around the world, improving capabilities for preparing and responding to infectious diseases and emerging health threats, building country public health capacity and maximizing organizational capacity," according to the strategy website.
Medunik Canada, is an orphan drug company dedicated to helping Canadians with rare diseases access therapies currently unavailable in Canada. Medunik Canada is proud to announce that it has signed an exclusive distribution agreement with Orphan Europe Recordati Group.
The opioid crisis in the United States is resulting in increased admissions to hospital intensive care units and in increased numbers of ICU deaths from opioid overdoses, according to new research published online, ahead of print in the Annals of the American Thoracic Society.
› Verified 4 days ago
| Provider Name | Therafit Enterprises Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1366772568 PECOS PAC ID: 8921255688 Enrollment ID: O20140730001077 |
News Archive
MorphoSys AG and G7 Therapeutics AG announced today that they have signed an agreement to collaborate on novel antibody therapeutics targeting G protein-coupled receptors and potentially other disease-related transmembrane proteins such as ion channels.
The Centers for Disease Control and Prevention (CDC) recently released its Global Health Strategy 2012-2015, which "outlines how CDC will leverage its core strengths to advance four overarching global health goals: improving the health and well-being of people around the world, improving capabilities for preparing and responding to infectious diseases and emerging health threats, building country public health capacity and maximizing organizational capacity," according to the strategy website.
Medunik Canada, is an orphan drug company dedicated to helping Canadians with rare diseases access therapies currently unavailable in Canada. Medunik Canada is proud to announce that it has signed an exclusive distribution agreement with Orphan Europe Recordati Group.
The opioid crisis in the United States is resulting in increased admissions to hospital intensive care units and in increased numbers of ICU deaths from opioid overdoses, according to new research published online, ahead of print in the Annals of the American Thoracic Society.
› Verified 4 days ago
| Provider Name | Back Home Therapy |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1235794926 PECOS PAC ID: 4385974203 Enrollment ID: O20190919000748 |
News Archive
MorphoSys AG and G7 Therapeutics AG announced today that they have signed an agreement to collaborate on novel antibody therapeutics targeting G protein-coupled receptors and potentially other disease-related transmembrane proteins such as ion channels.
The Centers for Disease Control and Prevention (CDC) recently released its Global Health Strategy 2012-2015, which "outlines how CDC will leverage its core strengths to advance four overarching global health goals: improving the health and well-being of people around the world, improving capabilities for preparing and responding to infectious diseases and emerging health threats, building country public health capacity and maximizing organizational capacity," according to the strategy website.
Medunik Canada, is an orphan drug company dedicated to helping Canadians with rare diseases access therapies currently unavailable in Canada. Medunik Canada is proud to announce that it has signed an exclusive distribution agreement with Orphan Europe Recordati Group.
The opioid crisis in the United States is resulting in increased admissions to hospital intensive care units and in increased numbers of ICU deaths from opioid overdoses, according to new research published online, ahead of print in the Annals of the American Thoracic Society.
› Verified 4 days ago
| Provider Name | Accessible Speech Therapy, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1689267064 PECOS PAC ID: 7214344282 Enrollment ID: O20210319000113 |
News Archive
MorphoSys AG and G7 Therapeutics AG announced today that they have signed an agreement to collaborate on novel antibody therapeutics targeting G protein-coupled receptors and potentially other disease-related transmembrane proteins such as ion channels.
The Centers for Disease Control and Prevention (CDC) recently released its Global Health Strategy 2012-2015, which "outlines how CDC will leverage its core strengths to advance four overarching global health goals: improving the health and well-being of people around the world, improving capabilities for preparing and responding to infectious diseases and emerging health threats, building country public health capacity and maximizing organizational capacity," according to the strategy website.
Medunik Canada, is an orphan drug company dedicated to helping Canadians with rare diseases access therapies currently unavailable in Canada. Medunik Canada is proud to announce that it has signed an exclusive distribution agreement with Orphan Europe Recordati Group.
The opioid crisis in the United States is resulting in increased admissions to hospital intensive care units and in increased numbers of ICU deaths from opioid overdoses, according to new research published online, ahead of print in the Annals of the American Thoracic Society.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Aliza Calm, 2600 Compass Rd, Glenview, IL 60026-8001 Ph: () - | Aliza Calm, 511 Jermor Ln Ste 102, Westminster, MD 21157-6152 Ph: (410) 871-2494 |
News Archive
MorphoSys AG and G7 Therapeutics AG announced today that they have signed an agreement to collaborate on novel antibody therapeutics targeting G protein-coupled receptors and potentially other disease-related transmembrane proteins such as ion channels.
The Centers for Disease Control and Prevention (CDC) recently released its Global Health Strategy 2012-2015, which "outlines how CDC will leverage its core strengths to advance four overarching global health goals: improving the health and well-being of people around the world, improving capabilities for preparing and responding to infectious diseases and emerging health threats, building country public health capacity and maximizing organizational capacity," according to the strategy website.
Medunik Canada, is an orphan drug company dedicated to helping Canadians with rare diseases access therapies currently unavailable in Canada. Medunik Canada is proud to announce that it has signed an exclusive distribution agreement with Orphan Europe Recordati Group.
The opioid crisis in the United States is resulting in increased admissions to hospital intensive care units and in increased numbers of ICU deaths from opioid overdoses, according to new research published online, ahead of print in the Annals of the American Thoracic Society.
› Verified 4 days ago
Karie Hadley, PHD Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 125 N Court St, Westminster, MD 21157 Phone: 410-751-3644 | |
Therafit Enterprises, Inc. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 511 Jermor Ln Ste 102, Westminster, MD 21157 Phone: 410-871-2494 | |
Wendy Beth Blum, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 125 N Court St, Westminster, MD 21157 Phone: 410-751-3033 | |
Sarah Frank, Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 511 Jermor Ln, Ste 102, Westminster, MD 21157 Phone: 410-871-2494 | |
Adriana Millan, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 125 N Court St, Westminster, MD 21157 Phone: 410-751-3033 | |
Brittany D Kauffman, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 125 N Court St, Westminster, MD 21157 Phone: 410-751-3033 | |
Ms. Mary Keelinn Leatherman, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Memorial Ave, Westminster, MD 21157 Phone: 410-848-3000 |